Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative Diseases.
Stephenson D, Aviles E, Bain LJ, Brumfield M, Carrillo M, Comery TA, Compton C, Corrigan B, Gordon MF, Jack CR Jr, Katz R, Logovinsky V, Satlin A, Marek K, Nicholas T, Polhamus D, Angersbach BS, Raghavan N, Romano G, Romero K, Shaw L, Woodcock J, Vradenburg G, Isaac M. Stephenson D, et al. Among authors: katz r. Ther Innov Regul Sci. 2013 Nov;47(6):632-638. doi: 10.1177/2168479013498386. Ther Innov Regul Sci. 2013. PMID: 30235546
Charting a path toward combination therapy for Alzheimer's disease.
Stephenson D, Perry D, Bens C, Bain LJ, Berry D, Krams M, Sperling R, Dilts D, Luthman J, Hanna D, McKew J, Temple R, Fields FO, Salloway S, Katz R. Stephenson D, et al. Among authors: katz r. Expert Rev Neurother. 2015 Jan;15(1):107-13. doi: 10.1586/14737175.2015.995168. Epub 2014 Dec 26. Expert Rev Neurother. 2015. PMID: 25540951 Review.
Building a roadmap for developing combination therapies for Alzheimer's disease.
Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D, Salloway S, Trojanowski JQ, Bountra C, Krams M, Luthman J, Potkin S, Gribkoff V, Temple R, Wang Y, Carrillo MC, Stephenson D, Snyder H, Liu E, Ware T, McKew J, Fields FO, Bain LJ, Bens C. Perry D, et al. Among authors: katz r. Expert Rev Neurother. 2015 Mar;15(3):327-33. doi: 10.1586/14737175.2015.996551. Expert Rev Neurother. 2015. PMID: 25708309 Free PMC article. Review.
Challenges, solutions, and recommendations for Alzheimer's disease combination therapy.
Hendrix JA, Bateman RJ, Brashear HR, Duggan C, Carrillo MC, Bain LJ, DeMattos R, Katz RG, Ostrowitzki S, Siemers E, Sperling R, Vitolo OV. Hendrix JA, et al. Among authors: katz rg. Alzheimers Dement. 2016 May;12(5):623-30. doi: 10.1016/j.jalz.2016.02.007. Epub 2016 Mar 24. Alzheimers Dement. 2016. PMID: 27017906
EU./U.S. CTAD Task Force on Alzheimer's Trial Populations.
Vellas B, Sampaio C, Bateman R, Boxer A, Carrillo MC, Cummings J, Dubois B, Hampel H, Katz R, Khachaturian Z, Gauthier S, Johnson K, Karlawish J, Mintun M, Petersen R, Rafii M, Robert P, Schneider LS, Siemers E, Sperling R, Tariot P, Touchon J, Weiner M, Andrieu S, Aisen P. Vellas B, et al. Among authors: katz r. J Prev Alzheimers Dis. 2014;1(2):110-116. doi: 10.14283/jpad.2014.6. J Prev Alzheimers Dis. 2014. PMID: 29255837
Considerations in the design of clinical trials for cognitive aging.
Reiman EM, Brinton RD, Katz R, Petersen RC, Negash S, Mungas D, Aisen PS. Reiman EM, et al. Among authors: katz r. J Gerontol A Biol Sci Med Sci. 2012 Jun;67(7):766-72. doi: 10.1093/gerona/gls124. Epub 2012 May 9. J Gerontol A Biol Sci Med Sci. 2012. PMID: 22573913 Free PMC article. Review.
Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force.
Vellas B, Bateman R, Blennow K, Frisoni G, Johnson K, Katz R, Langbaum J, Marson D, Sperling R, Wessels A, Salloway S, Doody R, Aisen P; Task Force Members. Vellas B, et al. Among authors: katz r. J Prev Alzheimers Dis. 2015 Jun;2(2):128-135. doi: 10.14283/jpad.2015.55. J Prev Alzheimers Dis. 2015. PMID: 26247004 Free PMC article.
2,564 results